Pure Global

Medgynax Contraceptive Tablet - Vietnam Registration 220000018/PCBA-HD

Access comprehensive regulatory information for Medgynax Contraceptive Tablet in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loแบกi A medical device is registered under number 220000018/PCBA-HD and manufactured by Pulipha Pharmaceutical Corporation.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
220000018/PCBA-HD
Registration Details
Vietnam MOH Registration: 220000018/PCBA-HD
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Medgynax Contraceptive Tablet
VN: Viรชn ฤ‘แบทt phแปฅ khoa Medgynax
Risk Class TTBYT Loแบกi A

Registration Details

220000018/PCBA-HD

000.00.16.H23-220210-0001

Medgynax

Company Information

Technical Details

Supports in reducing the symptoms of vaginal itching, cervical inflammation, and vaginitis accompanied by leukorrhea due to bacterial or fungal infection; helps maintain the normal pH of the vagina, and enhances the ability of cells to regenerate; supports the treatment of vaginal dryness

Dates and Status

Feb 15, 2022